Effects of Transcranial Direct Current Stimulation (tDCS) on Language
Stroke, Aphasia
About this trial
This is an interventional treatment trial for Stroke focused on measuring tDCS, treatment, brain stimulation
Eligibility Criteria
Inclusion Criteria:
- Patients with a language deficit from focal neurologic damage (e.g. stroke, tumor).
- Patients must be adults and have English-language fluency.
- Patients must be eligible to undergo MRI.
Exclusion Criteria:
- Advanced neurodegenerative disease (i.e. Stage 3 Alzheimer's disease) or neurologic disorder (e.g. idiopathic epilepsy, Parkinson's disease, ALS)
- Severe psychopathology (e.g. schizophrenia, bipolar disorder, acute major depressive episode)
- No suspected or diagnosed uncorrectable hearing or vision difficulties, or developmental disabilities (i.e. intellectual disability or learning disability).
- Contraindications to MRI such as claustrophobia, implanted electronic devices, MRI-incompatible metal in the body, extreme obesity, pregnancy, inability to lie flat, and inability to see or hear stimulus materials
Sites / Locations
- Medical College of WisconsinRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Active Comparator
Experimental
Active Comparator
Targeted tDCS with Phonologic-Focused Speech Therapy
Active Control tDCS with Phonologic-Focused Speech Therapy
Targeted tDCS with Semantic-Focused Speech Therapy
Active Control tDCS with Semantic-Focused Speech Therapy
Participants will receive phonologic-focused speech therapy with targeted anodal-tDCS for 10 therapy sessions before.
Participants will receive phonologic-focused speech therapy with active control tDCS for 10 therapy sessions.
Participants will receive semantic-focused speech therapy with targeted anodal-tDCS for 10 therapy sessions.
Participants will receive semantic-focused speech therapy with active control tDCS for 10 therapy sessions.